We covered:

• Menopause treatment in Europe and particularly in Holland

• Which countries in Europe are more progressive

• Menopause guidelines and doctor training in Europe

• The attitudes of women and practitioners (GPs) toward HRT in Europe

• What our guest is going to do with the 7 million euro grant for menopause research and how she got it.

• What hot flashes put us more at risk for

• Mental health and menopause

• Tips on how to ease through menopause and lower the symptoms

• How women differ from men in medicine and what needs to change in the curriculum and in the workplace in Europe

• The best way to get information on menopause

• The big myths of menopause in Europe

• Testosterone recommendations from the International Menopause Society

Dr. Dorenda Van Dijken  is born and raised in Amsterdam, Holland. Completed her medical education at the University of Amsterdam. Since 1994 she has been a gynecologist at the OLVG (Onze Lieve Vrouwe Gasthuis is a major clinical hospital situated near Oosterpark in Amsterdam in the Netherlands).

• Chairman Dutch Menopause Society.

• Board of IMS (International Menopause Society)

• Member of the Editorial Board of the website⁠ www.vrouwenindeovergang.nl⁠ .

• Contact point Social Card VGV Amsterdam. Member of the NVOG  (Dutch Society of Obstetrics and Gynecology) Guidelines writers group.

• Member of the Board of VPG (Reproductive Medicine department) Pillar NVOG.

• Teacher training in menopause nurses at Erasmus MC Rotterdam – Erasmus University Medical Center, the largest and one of the most authoritative scientific University Medical Centers in Europe

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

⁠https://www.imsociety.org/wp-content/uploads/2020/07/global-consensus-testosterone-english.pdf⁠

RESOURCES:

Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment ⁠https://pubmed.ncbi.nlm.nih.gov/11937111/⁠

⁠https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098532/levels⁠.

Association between testosterone levels and bone mineral density in females aged 40–60 years from NHANES 2011–2016:  ⁠https://www.nature.com/articles/s41598-022-21008-7⁠

Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: ⁠https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2604138⁠

Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments: ⁠https://pubmed.ncbi.nlm.nih.gov/11991434/⁠

Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: ⁠https://academic.oup.com/jcem/article/96/4/989/2720846⁠

Testosterone pellet therapy alone or in combination with low-dose E2 pellet therapy improved spine and hip BMD. ⁠https://www.sciencedirect.com/science/article/abs/pii/S1094695023000422